Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a report published on Tuesday morning. The brokerage issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $6.00 price target on shares of Arcadia Biosciences in a research report on Wednesday, August 21st.

Arcadia Biosciences Stock Performance

Shares of RKDA opened at $6.22 on Tuesday. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31. The firm has a market capitalization of $8.49 million, a price-to-earnings ratio of -1.45 and a beta of 1.18. The business’s fifty day moving average price is $4.03 and its two-hundred day moving average price is $3.29.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.